Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study.

Furlan A, van der Windt DJ, Nalesnik MA, Sholosh B, Ngan KK, Pealer KM, Ijzermans JN, Federle MP.

AJR Am J Roentgenol. 2008 Nov;191(5):1430-5. doi: 10.2214/AJR.07.3419.

PMID:
18941081
2.

Hepatic adenomatosis: MR imaging features.

De Kock I, Mortelé KJ, Smet B, Gillardin P, Pauwels W, De Backer AI.

JBR-BTR. 2014 Mar-Apr;97(2):105-8.

PMID:
25073243
3.

Case report: haemorrhagic hepatic adenoma--MR features.

Gaa J, Lee MJ, Saini S.

Clin Radiol. 1994 Oct;49(10):719-20.

PMID:
7955837
4.
5.

Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.

Schuchmann S, Weigel C, Albrecht L, Kirsch M, Lemke A, Lorenz G, Warzok R, Hosten N.

Eur J Radiol. 2007 Jun;62(3):416-22. Epub 2007 Jan 30.

PMID:
17267159
6.

MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.

Sofue K, Tateishi U, Tsurusaki M, Arai Y, Yamazaki N, Sugimura K.

Eur J Radiol. 2012 Apr;81(4):714-8. doi: 10.1016/j.ejrad.2011.01.123. Epub 2011 Feb 24.

PMID:
21353412
7.

Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.

Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T.

J Magn Reson Imaging. 2011 Aug;34(2):326-35. doi: 10.1002/jmri.22613.

PMID:
21780227
8.

The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Bohte AE, van Werven JR, Bipat S, Stoker J.

Eur Radiol. 2011 Jan;21(1):87-97. doi: 10.1007/s00330-010-1905-5. Epub 2010 Jul 31.

9.

[Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].

Bartolotta TV, Midiri M, Galia M, Carcione A, De Maria M, Lagalla R.

Radiol Med. 2001 Apr;101(4):219-29. Italian.

PMID:
11398050
10.

CT and MR imaging evaluation of hepatic adenoma.

Brancatelli G, Federle MP, Vullierme MP, Lagalla R, Midiri M, Vilgrain V.

J Comput Assist Tomogr. 2006 Sep-Oct;30(5):745-50.

PMID:
16954922
11.

Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.

Cantwell CP, Setty BN, Holalkere N, Sahani DV, Fischman AJ, Blake MA.

J Comput Assist Tomogr. 2008 Sep-Oct;32(5):738-44. doi: 10.1097/RCT.0b013e3181591d33.

PMID:
18830103
12.

Hepatocellular adenoma: MR imaging features with pathologic correlation.

Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D.

AJR Am J Roentgenol. 1995 Aug;165(2):303-8.

PMID:
7618545
13.

Hepatic adenomas associated with anti-epileptic drugs: a case series and imaging review.

Lee PU, Roberts LR, Kaiya JK, Lee CU.

Abdom Imaging. 2010 Apr;35(2):208-11. doi: 10.1007/s00261-009-9500-4. Epub 2009 Mar 13.

PMID:
19283429
14.

Prevalence, characteristics, and fate of intrahepatic nontumorous arterioportal shunts on MRI in patients with hepatic steatosis.

Wehrli NE, Mussi TC, Rosenkrantz AB.

J Comput Assist Tomogr. 2012 Jul-Aug;36(4):375-80. doi: 10.1097/RCT.0b013e31825a28be.

PMID:
22805663
15.

Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.

Berger-Kulemann V, Schima W, Baroud S, Koelblinger C, Kaczirek K, Gruenberger T, Schindl M, Maresch J, Weber M, Ba-Ssalamah A.

Eur J Surg Oncol. 2012 Aug;38(8):670-6. doi: 10.1016/j.ejso.2012.05.004. Epub 2012 May 30.

PMID:
22652037
16.

Case-orientated approach to the management of hepatocellular adenoma.

van der Windt DJ, Kok NF, Hussain SM, Zondervan PE, Alwayn IP, de Man RA, IJzermans JN.

Br J Surg. 2006 Dec;93(12):1495-502.

PMID:
17051603
17.

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.

Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.

Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.

PMID:
20057319
18.

Multidetector CT findings of spontaneous rupture of hepatic adenoma in a patient with hepatic adenomatosis.

Ulu EM, Uyuşur A, Ekici Y, Hunca C, Coşkun M.

Diagn Interv Radiol. 2009 Jun;15(2):135-8.

19.

Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.

Singhi AD, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson M.

Am J Surg Pathol. 2012 May;36(5):710-5. doi: 10.1097/PAS.0b013e3182495c73.

PMID:
22498821
20.

Supplemental Content

Support Center